Choline-phosphate cytidylyltransferase (EC 2.7.7.15) activity from 25-and 29-day-foetal rabbit lungs was inhibited in both the cytosolic and the microsomal fractions by preincubation with MgATP. The inhibition of the cytosolic enzyme was greater when measured with added phosphatidylglycerol (PG) than without (78-89% versus 50-55%), whereas the inhibition of the microsomal enzyme did not exhibit this distinction (66-72% versus 60-70%). When preincubated with the buffer alone, the cytosolic enzyme was activated to a greater extent by added PG than was the microsomal enzyme (13-14-fold versus 2-3-fold). However, after preincubation with MgATP, the cytosolic enzyme was activated to a smaller extent by added PG (3-6-fold). The inhibition of the enzyme by MgATP required a preincubation and was absent when ADP or AMP was substituted for ATP. Moreover, ATP analogues such as adenosine 5'-[/J,y-methylene]triphosphate and adenosine 5'-[y-thio]triphosphate also failed to inhibit the enzyme when substituted for ATP in the preincubation. The inhibition by MgATP was not affected by including cyclic AMP in the preincubation, but Ca2+ ions alone or plus diacylglycerol in the preincubation increased the inhibition slightly. The inhibition was abolished by incJuding an inhibitor of cyclic-AMP-dependent protein kinase in the preincubation. These observations, taken collectively, point to the inhibition of foetal pulmonary cytidylyltransferase through the phosphorylation of a protein and suggest that this key enzyme in lung surfactant production may be regulated through this mechanism.
INTRODUCTION
Choline-phosphate cytidylyltransferase (CTP: cholinephosphate cytidylyltransferase, EC 2.7.7.15) catalyses the transfer of a cytidylyl group from CTP to choline phosphate, forming CDP-choline and pyrophosphate. This is an important regulatory enzyme in the biosynthesis of phosphatidylcholine (PC) in several organs (Vance etal., 1980; Zelinski etal., 1980; Pritchard &Vance, 1981) , including the lung (Post et al., 1982) . In the latter, PC is the major constituent of the lung surfactant, which stabilizes the alveoli during breathing (Goerke, 1974) . During foetal development, the amount of PC in the alveolar lavage as well as in the whole lung increases markedly near term (Clements & Tooley, 1977; Ohno et al., 1978) . Studies of pool sizes indicate that there is a concomitant increase in the rate of the step catalysed by the cytidylyltransferase during the perinatal period (Tokmajian & Possmayer, 1980) . Studies with prematurely delivered rat foetuses suggest that the total amount of cytidylyltransferase itself does not change during this period, but that a cytosolic form of low activity is converted into a microsomal form of high activity (Weinhold et al., 1981) . The mechanism whereby such a process may occur is of obvious interest, considering that lung maturation is of paramount importance for the survival of the newborn and that the regulation of cytidylyltransferase is an important part of the lung maturation.
One of the mechanisms suggested for the regulation of cytidylyltransferase is that of reversible protein phosphorylation. Previous studies in liver indicate that this enzyme may be interconverted between two forms: a phosphorylated form, which does not associate with the endoplasmic reticulum and is of low activity, and a dephosphorylated form, which associates with the membrane and is of high activity .
There is increasing evidence that biosyntheses of fatty acids and other lipids can be controlled by protein phosphorylation (Hardie, 1981) . In general, biosynthetic pathways which are regulated through protein phosphorylation are inhibited when anabolic enzymes are phosphorylated. However, although incubation of hepatocytes with cyclic AMP analogues for short periods resulted in an inhibition of PC biosynthesis, further incubation resulted in a stimulation . In the lung studies, treatment of pregnant rabbits with hormones that promote protein phosphorylation and treatments of foetal-rat lung explants as well as transformed adult human lung cell lines with cyclic AMP analogues were conducted for prolonged periods, and an increase in PC biosynthesis was seen (Barrett et al., 1976; Gross & Rooney, 1977; Niles & Makarski, 1979 in the foetal lung (and in the liver) may be regulated through protein phosphorylation, though other complex phenomena may be occurring as well. Such a possibility led us to study the effect of conditions which favour protein phosphorylation on foetal pulmonary cytidylyltransferase, an important enzyme in foetal pulmonary maturation (Tokmajian & Possmayer, 1980 The homogenate was centrifuged at 1500 g for 5 min and the resulting supernatant was centrifuged at 12000 g for 10 min. The (post-mitochondrial) supernatant from the latter procedure was centrifuged at 100000 g for 60 min. The (microsomal) pellet was resuspended in the homogenization buffer at a protein concentration of approx. 3 mg/ml. Protein concentrations were measured by the Bradford assay (Bradford, 1976; Spector, 1978) , with essentially fatty-acid-and globulin-free bovine serum albumin (Sigma) as the standard. The cytosolic and the microsomal fractions were assayed while fresh for the phosphorylation and the cytidylyltransferase activities (Table 1 and Fig. 4) , and frozen in small portions in a solid-CO2/acetone bath and stored at -70°C for further studies of phosphorylation (Figs. 1, 2, 3 and 5) . Protocol for phosphorylation A portion (50 ,ll) of either the cytosolic or the microsomal fraction was preincubated with 2 mM-ATP, 10 mM-MgCl2 and 50 mM-Hepes at pH 7.0 in a total volume of 100 ,1 at 37°C for 10 min in a Dubnoff metabolic shaking incubator. In the control assays, the same volume of protein (50 ,1) was preincubated with the buffer alone in a similar fashion. In assays where effects of other compounds were to be tested on the phosphorylation, they were included in the standard phosphorylation preincubation, but the total volume was maintained at 100,1. At the end of the preincubation period, the samples were placed for 10 min in an ice/water bath before being assayed for cytidylyltransferase activity. Assay of cytidylyltransferase activity Assay mixtures contained 3 mM-[methyl-14C]choline phosphate (1.0 Ci/mol), 3.75 mm-CTP, 10 mM-MgCl2 and 50 mM-Hepes at pH 7.0 in a reaction volume of 50 ,ul. Assays with added PG contained 0.5 mg of PG (from egg lecithin; Sigma)/ml, a stock preparation of which was made by sonicating 5 mg of PG in 1 ml of 50 mM-Hepes buffer, pH 7.0.
Each assay was started by the addition of 20,1 of enzyme and incubated for 20 min at 37°C with shaking. The samples were placed in a boiling-water bath for 3 min to stop the reaction. They were then centrifuged in an Eppendorf 5412 centrifuge for 5 min, and the supernatant Pulmonary choline-phosphate cytidylyltransferase and phosphorylation thus located was scraped into vials, 0.2 ml of water and 5 ml of Scinti-Verse E (Fisher) scintillant were added, and the radioactivity was determined in a Nuclear Chicago PDS/3-Isocap scintillation counter. All enzymic activities are expressed in units of nmol of CDP-choline produced/min.
RESULTS
When either the cytosolic or the microsomal fraction from 25-or 29-day-foetal rabbit lung was preincubated with 10 mM-MgCl2 and 2 mM-ATP, the cytidylyltransferase activity was inhibited (Table 1 ). The enzymic activity in the cytosol was lower than that in the microsomal fraction after preincubation with buffer alone ('Control' values), but the former was activated more than the latter by added PG. On the other hand, the cytosolic activity was inhibited more by the preincubation with MgATP when it was measured with added PG than without. Such a distinction was not displayed by the microsomal activity. Inhibition of the foetal cytidylyltransferase required the simultaneous presence of Mg2+ ions and ATP (results not shown). Preliminary work showed that the inhibited enzyme remained inhibited, even after being subjected to gel filtration and freed of small molecules (P. McGarry & F. Possmayer, unpublished work). We found that the inhibition of the cytidylyltransferase by preincubation with MgATP as well as activation of the enzyme by PG were more reproducible when 5 mM-dithiothreitol was included in the homogenization buffer.
The foetal cytosolic cytidylyltransferase was inhibited by MgATP only after preincubation with MgATP ( Fig.  1 ). This is seen by comparing the steep negative slopes of the continuous lines (preincubations) with the shallow negative or positive slopes of the broken lines (no preincubation). Both sets of lines were obtained by a linear correlation of activities with ATP concentrations. Only the continuous lines show negative linear correlation coefficients which are significant at a 95% confidence level. In Figs. 1(a) and 1(b), the linear correlation coefficients for the continuous lines are -0.8014 and -0.9780, and for the broken lines + 0.4821 and -0.6024, respectively. Therefore the inhibition of cytidylyltransferase by MgATP was due to a time-dependent phenomenon, was in direct proportion to the ATP concentration and was not due to a simple inhibition by MgATP. Once again, the cytosolic activity measured with added PG was more sensitive to inhibition by preincubation with MgATP than was the activity measured without added PG.
The inhibition of cytidylyltransferase by a preincubation of the cytosol with Mg2+ and an adenine nucleotide required ATP specifically (Fig. 2) . Neither 2 mM-ADP nor 2 mM-AMP inhibited the enzyme when the same protocol was used. Moreover, the requirement of the inhibition for ATP appears to be due to a requirement for a transferable y-phosphate group on the adenine nucleotide (Fig. 3) Cytosols from one set of 25-day and another set of 29-day foetuses were preincubated at 37°C for 10 min with 10 mM-MgCl2 and 2 mM-ATP with no further additions, or with 2 mM-CaCl2 or with 2 mM-CaCl2 plus 4,g of 1,2-dioleoyl-sn-glycerol (diolein)/ml, and then assayed for cytidylyltransferase activity. The control (CONT.) values were obtained as described for Fig. 2 . The data in panels (a) and (b) were obtained as described for Fig. 1 (0.5 and 2.0 mM) and 1,2-dioleoyl-sn-glycerol (4 ,g/ml) increased the inhibition even further, but only to a small degree (Fig. 4) . [The results presented in Fig. 4 (Fig. 5) . Moreover, preincubation of the cytosol with the inhibitor alone, in the absence of MgATP, results in a mild stimulation of the cytidylyltransferase (20%), whether the activity is measured with or without added PG.
DISCUSSION
The studies described herein were undertaken to investigate whether the regulation of choline-phosphate cytidylyltransferase by phosphorylation was a general Vol. 232 phenomenon in organs other than liver, and to examine the possibility that control of cytidylyltransferase through phosphorylation could be involved in the regulation of surfactant production during foetal maturation. We were also interested to find out whether the anomalous increase in pulmonary PC biosynthesis in response to cyclic AMP analogues and hormones which operate through cyclic-AMP-mediated phosphorylation (Barrett et al., 1976; Gross & Rooney, 1977; Niles & Makarski, 1979) The present results demonstrate that foetal pulmonary cytidylyltransferase is inhibited by preincubation under phosphorylating conditions, both in the cytosolic and in the microsomal fractions. In the foetal rabbit (term is 31 days), choline incorporation into PC in lung slices increases 4-fold between days 25 and 29 of gestation . The amount of surfactant stored as lamellar bodies in type II cells increases sharply around 28 days of gestation (Ballard et al., 1977) . Consequently, we chose the gestational ages of 25 and 29 days to examine the response of cytidylyltransferase to phosphorylating conditions. The results demonstrate that the enzyme is equally susceptible to inhibition whether it is from foetuses before or after this critical transition.
No other exogenous chemical besides MgATP is necessary in the preincubation to inhibit the pulmonary cytidylyltransferase. In this feature, the protein kinase implicated in the inhibition of pulmonary cytidylyl- transferase seems similar to those implicated in the regulations of diacylglycerol acyltransferase (Haagsman et al., 1982) and hepatic cytidylyltransferase . However, in the case of acyltransferase, which is a microsomal enzyme, the protein kinase implicated appears to reside in the cytosol exclusively. With the foetal pulmonary cytidylyltransferase, both the cytosolic and the microsomal fractions contain the relevant protein kinase. Over 75% of the cytidylyltransferase in normal rat liver is in the cytosolic fraction, and, when incubated under phosphorylating conditions, this enzyme is not inhibited . However, the liver cytosolic enzyme is known to undergo an activation when allowed to age without added phospholipid (Fiscus & Schneider, 1966; Choy et al., 1977) , and this activation is prevented or decreased by the preincubation with MgATP. The foetal pulmonary cytosolic cytidylyltransferase is not activated through aging (Fig. la,-PG) and is inhibited by the preincubation under phosphorylating conditions. The microsomal enzyme in both the foetal lung and adult liver are inhibited by the same preincubation.
The inhibition of pulmonary cytidylyltransferase by MgATP requires a preincubation. Therefore (Yount et al., 1971a, b) .
ATP[S]
, on the other hand, is known to be a substrate for thiophosphorylation by cyclic-AMP-dependent and calmodulin-mediated protein kinases (Gratecos & Fischer, 1974; Kerrick et al., 1981) . These results do not preclude the possibility that a thiophosphorylation ofa polypeptide has taken place, but they do show that, even if that process had occurred, it did not lead to the inhibition of the cytidylyltransferase in the foetal pulmonary cytosol. Among the adenine nucleotides and analogues tested, only ATP has a transferable y-phosphate group, and it is the only nucleotide to bring about a significant inhibition of foetal pulmonary cytidylyltransferase, and this inhibition requires a preincubation along with Mg2+ ions. Collectively, these results indicate that the inhibition ofpulmonary cytidylyltransferase under phosphorylating conditions is mediated through protein phosphorylation.
Phosphorylating conditions also affect the foetal pulmonary enzyme's interaction with phospholipid activators. Cytosolic enzymes from both lung and liver are activated by anionic phospholipids, especially phosphatidylglycerol and lysophosphatidylethanolamine (Fiscus & Schneider, 1966; Choy & Vance, 1978; Feldman et al., 1980) . The presence of anionic phospholipid domains within intracellular membranes presumably provides an environment best suited for the activity of cytidylyltransferase (Feldman et al., 1980; Weinhold et al., 1983) . Preincubation of the pulmonary cytosolic enzyme with MgATP inhibits the activity measured with added PG to a greater extent (80-88%) than that measured without PG (44-52 % ). The activation caused by PG itself is decreased from 13-14-fold to 3-6-fold by the preincubation with MgATP. In contrast, the microsomal activity is inhibited to the same extent by the preincubation with MgATP, whether it is measured with or without added PG. The microsomal enzyme is activated less (2-3-fold) than the cytosolic enzyme (13-14-fold) by PG, and it is the latter activity that is more sensitive to inhibition when it is measured with added PG than without. Even though we have added a fairly high concentration of phospholipid (0.5 mg/ml) in our assay of the foetal cytosolic enzyme [concentration of phospholipid in adult lung cytosol, if prepared by our protocol, is 0.2 mg/ml for the rat, based on values reported by Feldman et al. (1980) ], there is no reversal of inhibition from phosphorylating conditions. Therefore, the phosphorylating conditions inhibit not only the pulmonary cytidylyltransferase itself, but also prevent the activation of the foetal cytosolic form through a mechanism which has been demonstrated to operate in vitro, but may operate in vivo as well (Chu & Rooney, 1985) . The conversion of the enzyme into a more active form, rather than an increased production of the enzyme, is considered critical in foetal pulmonary maturation, resulting in an increased production of phosphatidylcholine (Khosla et al., 1980; Possmayer et al., 1981) . Hence, the regulation of this important regulatory enzyme through protein phosphorylation can provide a means for a fine control of foetal pulmonary maturation.
These results differ from those obtained with the hepatic cytidylyltransferase . The rapid activation of the liver cytosolic enzyme by the phospholipid vesicles in the hepatic cytosol at 37°C is inhibited by including MgATP in the preincubation. Addition of 1 mg of phospholipid/ml to the assay, however, restores the activity to control values. Further addition of phospholipid increases the activity considerably.
The inhibition offoetal pulmonary cytidylyltransferase by the preincubation with MgATP is not affected by including 0.01 mm-and 0.1 mM-cyclic AMP in the preincubation. But adding Ca2+ ions or Ca2+ ions plus dioleoylglycerol to the preincubation inhibited the enzyme further, though with some sample-to-sample variation. Therefore the putative protein kinase which brings about the inhibition of pulmonary cytidylyltransferase does not seem to be cyclic-AMP-dependent, but may be Ca2+-mediated. The augmented PC biosynthesis observed after prolonged treatment of foetal lung cells with cyclic AMP analogues or hormones causing an increase in intracellular cyclic AMP (Barrett et al., 1976; Gross & Rooney, 1977; Niles & Makarski, 1979) can be explained most easily through the acceleration of pulmonary maturation, leading to an increase of type II cells (Rooney, 1979) .
The inhibition offoetal pulmonary cytidylyltransferase under phosphorylating conditions is reversed by an inhibitor of cyclic-AMP-dependent protein kinase, even though the inhibition itself does not require cyclic AMP. The same effect has been observed with the hepatic cytidylyltransferase also ). An explanation offered in the latter case is that the inhibitor may exert its effect on cytidylyltransferase by inhibiting the phosphorylation of another well-known protein, Inhibitor I. When Inhibitor I is phosphorylated, it becomes inhibitory to phosphoprotein phosphatase 1 (Cohen, 1982) . Therefore, when the phosphorylation of Inhibitor I is blocked, phosphoprotein phosphatase 1 becomes active. This phosphatase, which is known to act on glycogen synthase, glycogen phosphorylase and phosphorylase kinase (Cohen, 1982) , may also be involved in the dephosphorylation of cytidylyltransferase. This would explain the results observed with the inhibitor of cyclic-AMP-dependent protein kinase. The availability ofmethods ofpreparation for phosphoprotein phosphatase 1 and its inhibitors (Resink et al., 1983) should provide the means for testing this concept. This is an attractive idea, because it brings together the regulation of glycogen and phospholipid metabolism and because it has been suggested that glycogen metabolism is important to phosphatidylcholine biosynthesis in the foetal lung during the late part of gestation (Maniscalco et al., 1978) .
The foregoing results show that foetal pulmonary cytidylyltransferase is inhibited under conditions which favour protein phosphorylation, and that this inhibition also affects its interaction with phospholipid activators. Likely identities for the protein kinase and the phosphatase which may be involved in the regulation of this enzyme are suggested by our results, and further experiments are needed for confirmation. However, as with the hepatic enzyme, the results of studies on foetal pulmonary cytidylyltransferase have not demonstrated the direct phosphorylation of the enzyme. The results obtained so far can be explained by either a direct phosphorylation of the enzyme itself or that of a modulator protein, but in either case the results are consistent with a regulation through phosphorylation of a polypeptide. The isolation and identification of the phosphopeptide is necessary to prove and resolve this issue.
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